Chemed Corp
NYSE:CHE

Watchlist Manager
Chemed Corp Logo
Chemed Corp
NYSE:CHE
Watchlist
Price: 570.96 USD 1.36% Market Closed
Market Cap: 8.6B USD
Have any thoughts about
Chemed Corp?
Write Note

Intrinsic Value

The intrinsic value of one CHE stock under the Base Case scenario is 503.31 USD. Compared to the current market price of 570.96 USD, Chemed Corp is Overvalued by 12%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CHE Intrinsic Value
503.31 USD
Overvaluation 12%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Chemed Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for CHE cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about CHE?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Chemed Corp

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Chemed Corp

Provide an overview of the primary business activities
of Chemed Corp.

What unique competitive advantages
does Chemed Corp hold over its rivals?

What risks and challenges
does Chemed Corp face in the near future?

Has there been any significant insider trading activity
in Chemed Corp recently?

Summarize the latest earnings call
of Chemed Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Chemed Corp.

Provide P/S
for Chemed Corp.

Provide P/E
for Chemed Corp.

Provide P/OCF
for Chemed Corp.

Provide P/FCFE
for Chemed Corp.

Provide P/B
for Chemed Corp.

Provide EV/S
for Chemed Corp.

Provide EV/GP
for Chemed Corp.

Provide EV/EBITDA
for Chemed Corp.

Provide EV/EBIT
for Chemed Corp.

Provide EV/OCF
for Chemed Corp.

Provide EV/FCFF
for Chemed Corp.

Provide EV/IC
for Chemed Corp.

Show me price targets
for Chemed Corp made by professional analysts.

What are the Revenue projections
for Chemed Corp?

How accurate were the past Revenue estimates
for Chemed Corp?

What are the Net Income projections
for Chemed Corp?

How accurate were the past Net Income estimates
for Chemed Corp?

What are the EPS projections
for Chemed Corp?

How accurate were the past EPS estimates
for Chemed Corp?

What are the EBIT projections
for Chemed Corp?

How accurate were the past EBIT estimates
for Chemed Corp?

Compare the revenue forecasts
for Chemed Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Chemed Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Chemed Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Chemed Corp compared to its peers.

Compare the P/E ratios
of Chemed Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Chemed Corp with its peers.

Analyze the financial leverage
of Chemed Corp compared to its main competitors.

Show all profitability ratios
for Chemed Corp.

Provide ROE
for Chemed Corp.

Provide ROA
for Chemed Corp.

Provide ROIC
for Chemed Corp.

Provide ROCE
for Chemed Corp.

Provide Gross Margin
for Chemed Corp.

Provide Operating Margin
for Chemed Corp.

Provide Net Margin
for Chemed Corp.

Provide FCF Margin
for Chemed Corp.

Show all solvency ratios
for Chemed Corp.

Provide D/E Ratio
for Chemed Corp.

Provide D/A Ratio
for Chemed Corp.

Provide Interest Coverage Ratio
for Chemed Corp.

Provide Altman Z-Score Ratio
for Chemed Corp.

Provide Quick Ratio
for Chemed Corp.

Provide Current Ratio
for Chemed Corp.

Provide Cash Ratio
for Chemed Corp.

What is the historical Revenue growth
over the last 5 years for Chemed Corp?

What is the historical Net Income growth
over the last 5 years for Chemed Corp?

What is the current Free Cash Flow
of Chemed Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Chemed Corp.

Business Breakdown

Chemed Corp. is a distinguished player in the healthcare sector, known primarily for its two main subsidiaries: VITAS Healthcare and Chemed Home Health. VITAS is the nation’s leading provider of hospice and palliative care services, which cater to patients with life-limiting illnesses. This segment underscores Chemed’s dedication to enhancing the quality of life for patients and their families, focusing on compassionate care and support during critical times. Operating in a market increasingly underpinned by an aging population and a growing preference for home-based healthcare solutions, Chemed stands to benefit from favorable demographic trends. In addition, its Chemed Home Health division...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Chemed Corp

Current Assets 490.4m
Cash & Short-Term Investments 238.5m
Receivables 196.5m
Other Current Assets 55.5m
Non-Current Assets 1.3B
Long-Term Investments 126.6m
PP&E 335.1m
Intangibles 761.6m
Other Non-Current Assets 55.7m
Current Liabilities 264.8m
Accounts Payable 44.9m
Accrued Liabilities 175.9m
Other Current Liabilities 43.9m
Non-Current Liabilities 268.9m
Other Non-Current Liabilities 268.9m
Efficiency

Earnings Waterfall
Chemed Corp

Revenue
2.4B USD
Cost of Revenue
-1.5B USD
Gross Profit
847.8m USD
Operating Expenses
-446.6m USD
Operating Income
401.2m USD
Other Expenses
-99.5m USD
Net Income
301.7m USD

Free Cash Flow Analysis
Chemed Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In Q3 2024, VITAS Healthcare reported net revenues of $391.4 million, a 17.3% increase driven by higher admissions and a Medicare reimbursement rate rise. Adjusted EBITDA climbed 33.1% to $73.1 million, reflecting a solid margin of 18.6%. Conversely, Roto-Rooter’s revenues fell 6.9% to $214.8 million, with residential demand significantly down. Full-year EPS guidance for Chemed is now projected between $23.00 and $23.15, 13.3% to 14% above last year, as challenges in Roto-Rooter's sector continue. Expectations for VITAS in 2025 include continued strong growth, targeting high single to low double-digit increases in care days.

What is Earnings Call?
Fundamental Scores

CHE Profitability Score
Profitability Due Diligence

Chemed Corp's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
Positive Free Cash Flow
Positive 3-Year Average ROIC
62/100
Profitability
Score

Chemed Corp's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

CHE Solvency Score
Solvency Due Diligence

Chemed Corp's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
74/100
Solvency
Score

Chemed Corp's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CHE Price Targets Summary
Chemed Corp

Wall Street analysts forecast CHE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CHE is 676.94 USD with a low forecast of 639.33 USD and a high forecast of 743.4 USD.

Lowest
Price Target
639.33 USD
12% Upside
Average
Price Target
676.94 USD
19% Upside
Highest
Price Target
743.4 USD
30% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CHE?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for CHE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

CHE Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

CHE News

Other Videos

Profile

Chemed Corp Logo
Chemed Corp

Country

United States of America

Industry

Health Care

Market Cap

8.6B USD

Dividend Yield

0.39%

Description

Chemed Corp. engages in the provision of healthcare and maintenance services. The company is headquartered in Cincinnati, Ohio and currently employs 14,137 full-time employees. The Company’s segments include VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. The firm's VITAS business is operated in the state of Florida. The Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The firm services are provided through a network of Company-owned branches, independent contractors, and franchisees. The firm operates through its two wholly owned subsidiaries VITAS Healthcare Corporation and Roto-Rooter Group, Inc.

Contact

OHIO
Cincinnati
255 E 5th St Ste 2600
+15137626690.0
www.chemed.com

IPO

1971-05-27

Employees

14 137

Officers

CEO, President & Director
Mr. Kevin J. McNamara
VP, Controller, Principal Accounting Officer & CFO
Mr. Michael D. Witzeman CPA, MBA
VP & Director
Mr. Thomas C. Hutton
Executive Vice President
Mr. Nicholas Michael Westfall
VP, Chief Administrative Officer & Secretary
Ms. Lisa A. Reinhard
Director of Investor Relations
Sherri Warner
Show More
VP, Secretary & Chief Legal Officer
Mr. Brian C. Judkins
VP & Chief Strategy Officer
Mr. Nathan J. McNamara
Show Less

See Also

Discover More
What is the Intrinsic Value of one CHE stock?

The intrinsic value of one CHE stock under the Base Case scenario is 503.31 USD.

Is CHE stock undervalued or overvalued?

Compared to the current market price of 570.96 USD, Chemed Corp is Overvalued by 12%.

Back to Top